Balyasny Asset Management’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-53,622
| Closed | -$125K | – | 1927 |
|
|
2024
Q2 | $125K | Buy |
53,622
+32,305
| +152% | +$75.3K | ﹤0.01% | 1753 |
|
|
2024
Q1 | $95.3K | Buy |
21,317
+5,587
| +36% | +$25K | ﹤0.01% | 1877 |
|
|
2023
Q4 | $50.5K | Buy |
+15,730
| New | +$50.5K | ﹤0.01% | 1837 |
|
|
2023
Q1 | – | Sell |
-168,388
| Closed | -$1.06M | – | 2161 |
|
|
2022
Q4 | $1.06M | Buy |
168,388
+126,909
| +306% | +$798K | ﹤0.01% | 1239 |
|
|
2022
Q3 | $448K | Buy |
+41,479
| New | +$448K | ﹤0.01% | 1605 |
|
|
2021
Q2 | – | Sell |
-98,208
| Closed | -$3.47M | – | 1650 |
|
|
2021
Q1 | $3.47M | Buy |
+98,208
| New | +$3.47M | 0.02% | 697 |
|
|
2020
Q4 | – | Sell |
-147,059
| Closed | -$5.55M | – | 1123 |
|
|
2020
Q3 | $5.55M | Buy |
+147,059
| New | +$5.55M | 0.04% | 472 |
|